Table 1 List of genes for which expression increased five-fold or greater or decreased two-fold or greater
Fold Change | Gene Symbol | Gene Name |
|---|---|---|
115.7 | EGR1 | Early growth response 1 |
38.3 | FOS | v-Fos FBJ murine osteosarcoma viral oncogene homolog |
25.3 | ATF3 | Activating transcription factor 3 |
19.5 | GEM | GTP binding protein overexpressed in skeletal muscle |
17.1 | NR4A2 | Nuclear receptor subfamily 4, group A, member 2 |
16.6 | IL8 | Interleukin 8 |
15.9 | FST | Follistatin |
15.6 | PPP1R15A | Protein phosphatase 1, regulatory (inhibitor) subunit 15A |
13.7 | STC1 | Stanniocalcin 1 |
12.1 | MAFF | v-Maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
11.2 | CXCL2 | Chemokine (C-X-C motif) ligand 2 |
10.4 | TNFAIP3 | Tumor necrosis factor, alpha-induced protein 3 |
9.4 | MXD1 | MAX dimerization protein 1 |
9.1 | ARID5B | AT rich interactive domain 5B (MRF1-like) |
9.0 | NR4A3 | Nuclear receptor subfamily 4, group A, member 3 |
8.6 | JUN | v-Jun sarcoma virus 17 oncogene homolog (avian) |
7.8 | LOC153222 | adult retina protein |
7.4 | BRE | brain and reproductive organ-expressed (TNFRSF1A modulator) |
7.2 | MCTP1 | Multiple C2 domains, transmembrane 1 |
7.2 | DDIT3 | DNA-damage-inducible transcript 3 |
7.2 | FOSB | FBJ murine osteosarcoma viral oncogene homolog B |
7.1 | GDF15 | Growth differentiation factor 15 |
6.9 | CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
6.9 | DUSP6 | Dual specificity phosphatase 6 |
6.6 | CXCL1 | Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
6.5 | IL24 | Interleukin 24 |
6.3 | SPRY2 | Sprouty homolog 2 (Drosophila) |
6.1 | PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
6.0 | KLF6 | Kruppel-like factor 6 |
6.0 | IL11 | Interleukin 11 |
5.6 | IRAK2 | Interleukin-1 receptor-associated kinase 2 |
5.5 | IL6 | Interleukin 6 (interferon, beta 2) |
5.5 | HIST1H4H | Histone 1, H4h |
5.4 | FNIP1 | folliculin interacting protein 1 |
5.3 | HIST2H2BE | Histone 2, H2be |
5.2 | MCL1 | Myeloid cell leukemia sequence 1 (BCL2-related) |
5.1 | DUSP10 | Dual specificity phosphatase 10 |
5.1 | DHRS2 | Dehydrogenase/reductase (SDR family) member 2 |
5.1 | SYNE1 | Spectrin repeat containing, nuclear envelope 1 |
5.1 | HAS2 | Hyaluronan synthase 2 |
5.1 | PER1 | period homolog 1 (Drosophila) |
5.1 | ZBTB10 | zinc finger and BTB domain containing 10 |
-2.0 | FN1 | Fibronectin 1 |
-2.0 | BCL2L11 | BCL2-like 11 (apoptosis facilitator) |
-2.0 | COL5A1 | collagen, type V, alpha 1 |
-2.0 | VAV3 | vav 3 oncogene |
-2.0 | CSRP2BP | CSRP2 binding protein |
-2.0 | PRSS23 | protease, serine, 23 |
-2.1 | NRP2 | Neuropilin 2 |
-2.1 | DAPK1 | Death-associated protein kinase 1 |
-2.1 | CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) |
-2.2 | ST8SIA4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
-2.2 | RNASE4 | Ribonuclease, RNase A family, 4 |
-2.2 | FGG | Fibrinogen gamma chain |
-2.1 | STAT4 | Signal transducer and activator of transcription 4 |
-2.1 | NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 |
-2.3 | PCDH9 | Protocadherin 9 |
-2.2 | CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 |
-2.2 | ST8SIA4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
-2.3 | MAP2K6 | Mitogen-activated protein kinase kinase 6 |
-2.3 | LXN | latexin |
-2.3 | TM4SF20 | transmembrane 4 L six family member 20 |
-2.4 | AKR1C1///AKR1C2 | Aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)///aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) |
-2.7 | SLC40A1 | Solute carrier family 40 (iron-regulated transporter), member 1 |